Robert A. Winn Excellence in Clinical Trials: Clinical Investigator Leadership Award Grant

Robert A. Winn Excellence in Clinical Trials: Clinical Investigator Leadership Award Grant

Status: ACTIVE
Funder: Bristol Myers Squibb Foundation Inc
Last Updated: January 24, 2026

Summary

The Robert A. Winn Excellence in Clinical Trials Award, supported by the Bristol Myers Squibb Foundation, is a three-year program aimed at oncology graduates of the Winn CDA program. It focuses on enhancing clinical trials knowledge, leadership skills, and mentorship to foster independent clinical researchers. The initiative, led by the American Society of Clinical Oncology, seeks to train 25 clinical trialists over seven years, providing essential salary support and training-related resources.

Overview

NOTE: The Clinical Investigator Leadership Awards (Winn-CILA), supported by the Bristol Myers Squibb Foundation, are three-year career and leadership awards designed for oncology graduates of the Winn CDA program. Please see the Career Development Award (Winn CDA) here. Robert A. Winn Diversity in Clinical Trials: Clinical Investigator Leadership Award (Winn CILA) The leadership and training program is led by the American Society of Clinical Oncology and funded by the Bristol Myers Squibb Foundation and includes collaboration with the members of the National Cancer Institute’s National Clinical Trials Network (NCTN). The program launched in early 2024 and has a goal of training a total of 25 clinical trialists over a seven-year period. The program will provide salary support for the participants during their award term, support for the NCTN cooperative groups, and other training-related costs.

Eligibility

You can learn more about this opportunity by visiting the funder's website. Applicants must meet the following criteria:Be a current Winn CDA Scholar in Oncology Completed an oncology subspeciality training. Be employed by an institution that is a current/active member of an NCI National Clinical Trials Network. Be able to commit at least 30% of full- time effort in during the award period, as confirmed in an institutional Letter of Support.